Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...

According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...

Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...